In a recent SEC filing, Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) disclosed its unaudited consolidated balance sheet as of January 31, 2025. The Edison, New Jersey-based pharmaceutical company, which ...

In a recent SEC filing, Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) disclosed its unaudited consolidated balance sheet as of January 31, 2025. The Edison, New Jersey-based pharmaceutical company ...

Among the broader markets, the Nifty Smallcap100, and Nifty Midcap100 indices settled higher by 0.69 per cent, and 0.05 per cent respectively ...

Business term loans can be among the least expensive forms of business financing and are good for making long-term investments in your business. Many, or all, of the products featured on this page ...

Your body is made of cells -- trillions of them. Cells are the basic building blocks of people and all other living things. Researchers study them to learn more about health and diseases.

Dividend amount and dividend per share are quoted in the currency of the stock selected. Please note that past performance is not a reliable indicator of future returns. Important Information Please ...

Featured here, the Balance Sheet for TNF Pharmaceuticals Inc, which summarises the company's financial position including assets, liabilities and shareholder equity for each of the latest 10 period ...

Featured here, the Balance Sheet for Zomedica Pharmaceuticals Corp, which summarises the company's financial position including assets, liabilities and shareholder equity for each of the latest 10 ...

Naturally given its location, it's child-friendly — and opens just in time for February half term. From 15 February BARBIE: Museum curators have worked in partnership with Mattel Inc ...

Featured here, the Balance Sheet for Acurx Pharmaceuticals LLC, which summarises the company's financial position including assets, liabilities and shareholder equity for each of the latest 10 period ...

Jazz Pharmaceuticals plc(NASDAQ:JAZZ) reported Q4 2024 results and provided guidance for 2025. The company ended the year on a strong note, beating analyst estimates ...